Helping biotech and industry make the connection
RareKids-CAN partners with industry to strengthen and accelerate the pediatric rare disease clinical trials ecosystem across Canada. Through our coordinated national network of pediatric research sites, investigators, patient and family partners, and centralized operational supports, we help streamline study planning, feasibility assessments, harmonized ethics review, site start up and execution within Canada’s pediatric rare disease clinical trial landscape.
We can help you connect with the expertise, infrastructure, sites and research teams needed to move research forward.
Benefits of partnering with RareKids-CAN
Faster site engagement
Accelerate study start-up through trusted investigator relationships and targeted outreach by our Clinical Trial Navigators, improving response rates and reducing delays. Through our tailored approach, we have achieved a 500% higher engagement rate with investigators and trial sites compared with traditional, one-by-one outreach approaches used by industry partners.
Reduced operational burden
Streamline site identification and investigator engagement with one coordinated process, minimizing duplication and saving valuable time and resources.
Simplified national access
Access Canada’s pediatric rare disease clinical trial community through a single point of contact, connecting you with investigators, experts, and trial sites nationwide.
Make informed decisions earlier
Gauge site interest, investigator availability, and study alignment early, helping you prioritize high potential sites and confidently plan your pediatric rare disease clinical trial.
How we support industry
Need to expand your pediatric rare disease clinical trial across Canada? Leverage RareKids-CAN’s national network and established investigator relationships to identify potential sites and accelerate engagement.
Our Clinical Trial Navigators, based at 16 pediatric institutions and affiliated hospitals across Canada, leverage established relationships to conduct targeted outreach on behalf of study teams. This personalized approach helps improve engagement, accelerate investigator responses, and streamline the site identification site identification for pediatric rare disease clinical trials.
Our proven relationship driven approach enables rapid investigator engagement and response, helping industry identify and connect with potential sites more efficiently.
Have Questions?
RareKids-CAN is here to help. If you can’t find answers to your questions in our FAQs, please don’t hesitate to contact us.